 LEXINGTON, Mass. and AMSTERDAM, The Netherlands, May 03, 2021 GLOBE NEWSWIRE -- uniQure N.V. NASDAQ: QURE, a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences: 